CA2089476A1 - Inhibition of herpesviridae infection by antisense oligonucleotides - Google Patents

Inhibition of herpesviridae infection by antisense oligonucleotides

Info

Publication number
CA2089476A1
CA2089476A1 CA002089476A CA2089476A CA2089476A1 CA 2089476 A1 CA2089476 A1 CA 2089476A1 CA 002089476 A CA002089476 A CA 002089476A CA 2089476 A CA2089476 A CA 2089476A CA 2089476 A1 CA2089476 A1 CA 2089476A1
Authority
CA
Canada
Prior art keywords
oligomer
virus
gene
target sequence
complementary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002089476A
Other languages
English (en)
French (fr)
Inventor
Bernard Roizman
Kameron W. Maxwell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genta Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2089476A1 publication Critical patent/CA2089476A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • C12N15/1133—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against herpetoviridae, e.g. HSV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/321—2'-O-R Modification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/352—Nature of the modification linked to the nucleic acid via a carbon atom
    • C12N2310/3521—Methyl

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CA002089476A 1990-08-15 1991-08-13 Inhibition of herpesviridae infection by antisense oligonucleotides Abandoned CA2089476A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56850190A 1990-08-15 1990-08-15
US568,501 1990-08-15

Publications (1)

Publication Number Publication Date
CA2089476A1 true CA2089476A1 (en) 1992-02-16

Family

ID=24271562

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002089476A Abandoned CA2089476A1 (en) 1990-08-15 1991-08-13 Inhibition of herpesviridae infection by antisense oligonucleotides

Country Status (10)

Country Link
EP (1) EP0547149A4 (es)
JP (1) JPH06500469A (es)
KR (1) KR930701105A (es)
AU (2) AU8617691A (es)
CA (1) CA2089476A1 (es)
IE (1) IE912883A1 (es)
IL (1) IL99172A (es)
NZ (1) NZ239372A (es)
TW (1) TW226408B (es)
WO (1) WO1992003051A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2105595A1 (en) * 1992-09-23 1994-03-24 Ramaswamy Narayanan Antisense polynucleotides
CA2190998A1 (en) 1994-06-01 1995-12-07 Sudhir Agrawal Branched oligonucleotides as pathogen-inhibitory agents
WO1996013608A2 (en) * 1994-10-28 1996-05-09 Innogenetics N.V. Polynucleic acid sequences for use in the detection and differentiation of prokaryotic organisms
CA2223032A1 (en) * 1997-02-21 1998-08-21 Smithkline Beecham Corporation Use of hsv-1 ul-15 and vp5 in identifying anti-viral agents
CN1694959B (zh) 2002-09-13 2013-09-18 雷普利瑟公司 非序列互补的抗病毒寡核苷酸

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ209840A (en) * 1983-10-17 1988-11-29 Kaji Akira A method of inhibiting viral propagation by hybridising dna with the viral rna thus blocking its action
US5248670A (en) * 1990-02-26 1993-09-28 Isis Pharmaceuticals, Inc. Antisense oligonucleotides for inhibiting herpesviruses
WO1992005284A1 (en) * 1990-09-21 1992-04-02 University Of Maryland Compositions and methods for inhibiting growth or replication of viruses

Also Published As

Publication number Publication date
NZ239372A (en) 1997-06-24
WO1992003051A1 (en) 1992-03-05
AU3776395A (en) 1996-02-29
IE912883A1 (en) 1992-02-26
EP0547149A4 (en) 1993-09-01
TW226408B (es) 1994-07-11
EP0547149A1 (en) 1993-06-23
AU8617691A (en) 1992-03-17
JPH06500469A (ja) 1994-01-20
KR930701105A (ko) 1993-06-11
IL99172A0 (en) 1992-07-15
IL99172A (en) 1999-03-12

Similar Documents

Publication Publication Date Title
US5532130A (en) Methods and compositions for sequence-specific hybridization of RNA by 2'-5' oligonucleotides
US5596091A (en) Antisense oligonucleotides comprising 5-aminoalkyl pyrimidine nucleotides
US5789573A (en) Antisense inhibition of ICAM-1, E-selectin, and CMV IE1/IE2
JP6382150B2 (ja) ｍＲＮＡ前駆体のスプライシングを修飾するＥＮＡ核酸医薬
US6140482A (en) Primary phosphoramidate internucleoside linkages and oligonucleotides containing the same
US9416361B2 (en) Splice-region antisense composition and method
US6043352A (en) 2'-O-Dimethylaminoethyloxyethyl-modified oligonucleotides
US5656612A (en) Antisense oligonucleotide modulation of raf gene expression
CA2817002C (en) Base modified oligonucleotides
Lebreton et al. Synthesis of thymidine dimer derivatives containing an amide linkage and their incorporation into oligodeoxyribonucleotides
WO1995014706A1 (en) Pna-dna-pna chimeric macromolecules
WO1997030067A1 (en) Sugar-modified gapped oligonucleotides
MXPA04007403A (es) Oligonucleotidos que comprenden segmentos alternos y usos de los mismos.
AU657191B2 (en) 3'-derivatized oligonucleotide analogs with nonnucleotidic groupings, their preparation and use
CA2419563C (en) Chimeric antisense of arabinofuranose analogue and deoxyribose nucleotides
US6033909A (en) Oligonucleotide analogs, their preparation and use
CA2089476A1 (en) Inhibition of herpesviridae infection by antisense oligonucleotides
Farooqui et al. Effect of structural variations in cholesteryl-conjugated oligonucleotides on inhibitory activity toward HIV-1
AU781297B2 (en) Chimeric DNA/RNA ribozymes containing propanediol
US20020052331A1 (en) Compositions and methods for antisense inhibition of protein translation
Shinozuka et al. Novel DNA Analog for Potential Gene Regulating Agent. A Convenient Synthesis of. ALPHA.-Oligodeoxyribonucleotide Phosphorothioate Bearing 3'-Monophosphate.
WO1996018640A9 (es)

Legal Events

Date Code Title Description
FZDE Discontinued